Investment Q&A

Q: Hi 5i Team,

This is just a comment about today's market 6% decline. The Wall Street Journal published a scathing article today about drug makers who don't spend any money and on R&D and sky-rocket drug prices. In my opinion Concordia was unfairly criticized in the article as as being one of the worst offenders.

Thanks, Shane

Q: Technology
The following report was published this am by TD Waterhouse, and I although I have similar confidence I was wondering if you agree. Also what else would you recommend, I currently have ESL which is performing quite well, was considering Kxs and would this be appropriate for an RRSP. Should we be considering a US holding
I look forward to your usual excellent response.

"The technology sector has, in our view, taken over market leadership within the
broader U.S. equity market. Not only do we see relative price strength in the S&P
500 Technology large-cap sector, but also in the S&P 600 Technology small-cap
sector. Other growth sectors do not exhibit this wide breadth in relative price
strength. This has become most evident in the healthcare sector, which has lost
market leadership, in our view, and in the consumer discretionary, where small-cap
names are exhibiting very poor relative price strength. In addition, the technology
sector has historically been highly insulated from potentially rising interest rates
and higher commodity prices, unlike consumer stocks. It also has less relative
sensitivity to a rising U.S. dollar. We continue to take the view that the market is
closely following the sector rotations of the later 1990s — a period when the
technology sector dominated performance (also in a rising U.S. dollar and interest
rate environment). We would not expect the technology sector to enter into a
speculative bubble as we saw at the end of that cycle, but we do expect its relative
strength to continue. We are well overweight technology in both our large- and
small-cap model portfolios.
Following its positive Q4/F15 results (year-end September) and the
subsequent upward revisions to F2016 ($3.43 to $3.47) and F2017 ($3.62 to
$3.75) consensus EPS estimates, we are raising our position in CGI Group
Inc. (GIB.A-T, $56.90) to 3.0% from 1.9%".

Q: Please comment on which REIT provides better value and yield going forward as follows (excluding exchange rate for BPY):
Brookfield Property Partners ($1.06 / $22.95 = 4.62 %)
Boardwalk REIT ($2.06 / $47.10 = 4.33 %)
Canadian Apartment REIT ($1.22 / $26.53 = 4.61 %)
BPY has had a good run in the last 18 months (+40 %) while BEI-UN has declined in the last year due to the oil meltdown. CAR-UN has seen less increase/decrease than BEI-UN.
I have had a good run on BPY-UN and need to trim a little for portfolio management. I am underweight on my allocation for apartment REITs and slightly overweight on office/commercial REITs in my portfolio.

Thanks for the great service.

Q: Hello Peter
I own Alergan stock and Pfizer & Alergan announced today 160 billion merger

The deal values Allergan at $363.63 per share, about 30% more than its price when reports of a deal first surfaced last month.

Allergan shareholders will get 11.3 shares of the new company for each of their shares. Pfizer shareholders will get one share of the new company’s stock for each of their shares.

After completion of the deal, which must be approved by U.S. and European regulators, Pfizer shareholders would own 56% of the combined company.
My question is what should I do with my shares, sell or wait for closing of the deal and what is good and what is bad in this deal for me as a shareholder.

Regards Andrew B.

Q: Noticed SJ was up nicely today and hit a new 52 week high. Couldn't find any news. Any idea why the nice move?


Thanks

Q: Do you have a view regarding today's press release and the carbon tax news from the AB government?

Q: In response earlier today you indicated insiders own 9%. AGM info and 2014 press releases indicate Oakwest Corportation (Beutel Family Office) owns 29%/31% respectively. Would you view Beutel family involvement as positive, negative or neutral?

Q: You thoughts on the asset sale to Bell would be appreciated, in particular how this may change free cash flow (and dividend protection) going forward and is this not also setting up the value of the company in the event of a buy-out?

The sale price for Movie Central, Encore and HBO Canada was $211 million. They state that this was derived by taking adjusted 2015 segment EBITDA multiple for Pay TV of 6.7x.

Fiscal 2015 Corus had $260 million of TV segment profit.

Even ignoring the value of the radio stations (let's say that they wash out against 'Corporate' and other costs in the event of a break-up or buy-out), wouldn't this put the value (based on what Bell paid for the above) of the remaining TV component at $1,530 million ($260 million x 6.7 - $211 million), or above $17.50/share? Or am I taking a too simplified view of the break-up value of the assets?

Q: It has been my understanding that the amounts go to insipra through an assignment of receivables. The details and legals I do not know, but it is a little like a factor system.

Q: Peter and Team,

With the environmental regulation changes happening in Alberta and the seemingly relentless drive of public policy toward a "carbon free future" at any cost, doesn't it seem like the writing is on the wall for a company like BEP.UN to move higher over time? Do you think the market will recognize this?

Q: Could you comment please on the sale of Allstream. How does the deal rate? Does the sale impact MBT growth prospects and does the Allstream sale make it likely BCE or Telus would / could buy MBT soon? Thanks so much.

Q: A complimentary article on David Baazov in the Nov. FP Magazine here: http://business.financialpost.com/financial-post-magazine/high-school-dropout-has-turned-amaya-into-a-gaming-and-publicly-traded-powerhouse

I did not know that head office is in the Isle of Man. Does that mean that some or all of the executives work out of there or is it just a shell office?

Q: I would appreciate your opinion of FAF.us at today's price of $38.19.

Q: They are offering to swap these share for share in a new entity they are calling Brookfield preferred "Units" as opposed to shares, upping the dividend slightly. Is this a good deal, and more importantly would the "Units" be tradable on the TSX? I am not underwater on these, and I am getting roughly 6% on my original investment, any need to do the trade or will it eventually be mandatory. The language in their prospectus is confusing.
John

Q: PEO has been dropping on big volume, any thoughts? Does 5i go and meet with management of any of the followed companies, I've never seen a mention?

Q: Thinking of doing some bottom fishing here with either Finning or Caterpillar which both are long term performers. Any thoughts on my strategy of picking up some shares on the cheap for a long term hold and would you prefer one company over the other?

Q: What is the risk/reward profile for MTL?
It has trended down - as expected - ytd to the point where the yield is ~ 7.4%.

I am searching for reliable dividend income stocks with more upside potential than downside risk.

I know that is asking a lot these days but would MTL fit into that niche?


Thanks.

Q: Your opinion on SPN please. Is it a buy at $.48?
Thanks, Klaus

Q: I would appreciate an update on bgm since your May 15th comments.
Thank you,
Bob.

Q: Could you please provide a update and a buy sell or hold many thanks.